About Us | Contact Us | E-Paper

Govt to support indigenously developed Cancer radiation technology: Dr Jitendra

Post by on Thursday, May 26, 2022

First slide
New Delhi, May 25: Government will support indigenously developed latest Cancer radiation technology in the form of high-powered Magnetron for specific use as therapy in Cancer patients. 
This was disclosed here on Wednesday by the Union Minister of State, Dr Jitendra Singh. He said this after the signing of anMoU between Technology Development Board (TDB) of Department of Science & Technology and M/s Panacea Medical Technologies Pvt. Ltd., Bangalore to provide financial support for development and commercialisation of “S Band Tunable Magnetron for Particle Accelerators". TDB has agreed to offer loan assistance of ?4.87 crores, out of the total project cost of ?9.73 crores to the company.
Dr Jitendra Singh said, high-powered Magnetron developed by CSIR-CEERI (Central Electronics Engineering Research Institute), Pilani for commercial use by Panacea Company will be a pathbreaking technology for Oncologists to treat even 2 mm diameter brain tumour with precision radiation with very little side-effects. He said, this will not only increase efficacy, but also prove cost effective in treatment of micro and major tumours.
Dr Jitendra Singh said, with the handholding of TDB, Panacea developed India’s first most advanced & innovative SBRT enabled Linear Accelerator (LINAC), Siddharth II, capable of performing treatment modalities like 3DCRT, VMAT, IMRT, SBRT and SRS. He said, this machine with U.S. FDA, 510(k) clearance has been launched on Technology Day celebrated on 11th May 2022 and this is the third brand in the world which is ready for the market beside two global giants UK and Japan. The Minister further added that in tune with Modi Government’s mantra of “Make in India” and “Make for the World”, the machine can be exported to many countries in the world as it has already received US FDA clearance.
Currently, our economy is dependent on the use of imported magnetrons in various applications related to NDT, radar & other industrial applications in addition to medical applications. This technology can be further extended for other applications ensuring seamless supply of RF source to Medical LINAC Manufacturers across the globe.
Dr Jitendra Singh said, TDB supporting Panacea Medical Technologies for “Development and Commercialization of S Band Tunable Magnetron for Particle Accelerators” would enable Panacea one step ahead to further lower the cost of Siddharth II to make the cancer treatment more affordable to the common man. This also exemplifies the best Industry Academia linkage promoting market driven R&D to benefit the society at large.
Dr Jitendra Singh said, medical devices have been identified as a priority sector by NarendraModi Government under the flagship 'Make in India' program and it is committed to strengthen the indigenously manufacturing ecosystem of the country. He said, currently, India is the fourth largest medical devices market in Asia, after Japan, China & South Korea and positioned 20th in the global market. India imports about 86% of its requirement of medical equipment and almost 100% of high-end medical equipment, the Minister added.
Dr Jitendra Singh said, as per the study of global markets, magnetron holds a huge demand globally, as it is essential for all types of linear accelerators, industrial heating equipment, radar systems, medical applications, NDT & others industries. He said India would be the third country to achieve this feat. England and Japan hold around 80% - 90 % of the global market. The Minister said, for making the Indian Healthcare Ecosystem a robust sector, TDB is providing an impetus to India’s vision of becoming a global manufacturing hub for medical devices.
 
 

Latest Post